The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...

Crude oil-derived substances in the candy have been linked to health problems—and the regulations that have allowed their use ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...